Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

NCT02274766 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyskinesia
Levodopa-Induced Dyskinesia (LID)
Parkinson's Disease (PD)

Interventions

DRUG: ADS-5102
OTHER: Placebo

Sponsor

Adamas Pharmaceuticals, Inc.